Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹61.55, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 15% over the past year. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹61.90, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 22x in the Chemicals industry in India. Total loss to shareholders of 10% over the past year. New Risk • Nov 18
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 29% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (29% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹1.47b market cap, or US$16.6m). New Risk • Nov 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.2% average weekly change). Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹1.57b market cap, or US$17.7m). 공지 • Nov 14
Indian Phosphate Limited to Report First Half, 2026 Results on Nov 14, 2025 Indian Phosphate Limited announced that they will report first half, 2026 results on Nov 14, 2025 Valuation Update With 7 Day Price Move • Nov 14
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to ₹62.90, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 33% over the past year. 공지 • Sep 08
Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025 Indian Phosphate Limited, Annual General Meeting, Sep 29, 2025, at 11:30 Indian Standard Time. Reported Earnings • Sep 08
Full year 2025 earnings released: EPS: ₹3.92 (vs ₹7.21 in FY 2024) Full year 2025 results: EPS: ₹3.92 (down from ₹7.21 in FY 2024). Revenue: ₹8.86b (up 24% from FY 2024). Net income: ₹86.9m (down 34% from FY 2024). Profit margin: 1.0% (down from 1.8% in FY 2024). The decrease in margin was driven by higher expenses. New Risk • Sep 04
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended March 2024. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported March 2024 fiscal period end). Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.35b market cap, or US$15.4m). Board Change • Aug 04
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • May 28
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹52.25, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. New Risk • Apr 01
New major risk - Revenue and earnings growth Revenue has declined by 7.0% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 7.0% over the past year. High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.13b market cap, or US$13.2m). New Risk • Mar 22
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (69% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₹1.21b market cap, or US$14.1m). Board Change • Mar 06
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 19
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Sep 19
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹115, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 36x in the Chemicals industry in India. Board Change • Sep 04
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Shailesh Jain was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.